Cumberland Pharmaceuticals Inc.
CPIX
Get informed when a big investor buys or sells
+ FollowMarket Cap$92.15M
Close$
$13.36
138.1% upside
Current Fair Value
138.1% upsideUndervalued by 138.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $92.15 Million |
|---|---|
| Enterprise Value | $91.21 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.19 |
| Beta | -0.06 |
| Outstanding Shares | 14,960,210 |
Return
| Return on Equity | -33.42% |
|---|---|
| Return on Assets | -10.19% |
| Return on Invested Capital | -20.10% |
Valuation & Multiples
| P/E Ratio | -12.72 |
|---|---|
| PEG | 3.64 |
| Price to Sales | 2.81 |
| Price to Book Ratio | 5.61 |
| Enterprise Value to Revenue | 2.17 |
| Enterprise Value to EBIT | -12.43 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.47 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3869▼ 107.56% |
|---|---|
| Total Calls | 108,800▲ 270.07% |
| Total Puts | 42,100▼ 2.09% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 18.46%▼ 1.32% |
|---|---|
| Total Invested | $8.97M▼ 23.77% |
| Investors Holding | 34▲ 3.00% |
ESG Score
No data
About Cumberland Pharmaceuticals Inc.
90 employeesCumberland Emerging Technologies, Inc.(www.cet-fund.com)is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN and WinHealth Pharma. The mission of CET is to bring biomedical technologies and produ...